Nom du produit:6-(Methoxymethyl)-2-phenylpyrimidin-4(3H)-one
IUPAC Name:6-(methoxymethyl)-2-phenyl-3,4-dihydropyrimidin-4-one
- CAS：339278-89-6
- Formule moléculaire：C12H12N2O2
- Pureté：95%
- Numéro de catalogue：CM309130
- Poids moléculaire：216.24
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:339278-89-6
- Formule moléculaire:C12H12N2O2
- Point de fusion:-
- Code SMILES:O=C1NC(C2=CC=CC=C2)=NC(COC)=C1
- Densité:
- Numéro de catalogue:CM309130
- Poids moléculaire:216.24
- Point d'ébullition:
- N° Mdl:
- Stockage:Store at 2-8°C.
Category Infos
- Pyrimidines
- Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.
Column Infos
- Selatogrel
- Selatogrel is an investigational, potent, fast-acting, reversible, and highly selective P2Y12 inhibitor, being developed for the treatment of an acute myocardial infarction (AMI) in patients with a recent history of AMI. It is intended to be self-administered subcutaneously via a drug delivery system (autoinjector).
This novel, self-administered emergency agent has the potential to protect heart muscle in the very early phase of an AMI – in the crucial time between symptom onset and first medical attention – so as to treat the ongoing AMI and prevent early death.
Recherche 
+86 21 5895 0110 
